backtop

Print 22 comment(s) - last by michael2k.. on Jan 17 at 6:24 PM
The weekly injection removed 80 percent of senile plaques that cause Alzheimer's

Canadian researchers have come one giant step closer to finding treatment for those with Alzheimer's disease, and even a preventative vaccine.

The team of researchers hail from Université Laval, CHU de Québec, and pharmaceutical firm GlaxoSmithKline (GSK), and was led by Dr. Serge Rivest, professor at Université Laval's Faculty of Medicine and researcher at the CHU de Québec research center.

A key part of Alzheimer's disease is the production of a toxic molecule called amyloid beta. The body's defenders, called microglial cells, cannot eliminate amyloid beta, and that's when senile plaques are formed.

But the new study gives the brain's immune cells a boost through monophosphoryl lipid A, called MPL, which is a vaccine that has already been proven safe through its use with GSK.

After giving mice with Alzheimer's symptoms weekly injections of MPL for 12 weeks, about 80 percent of senile plaques were eliminated. Also, the mice showed improvement in cognitive function.

According to the team, the MPL injection could not only slow the progression of the disease in patients already showing symptoms, but also be used as a preventative vaccine for those at risk.

Last September, the cancer drugs erlotinib (Tarceva) and gefitinib (Iressa) were used to cure Alzheimer's in fruit flies and rats.

Source: Science Daily


Comments     Threshold


This article is over a month old, voting and posting comments is disabled
RE: Sign Me Up!
By gamerk2 on 1/16/2013 11:42:04 AM , Rating: 2
To be fair, the Federal government has to reimburse medical companies to create vaccines, because they aren't profitable. As a result, most Vaccine research is done in Medical Labs, not by Medico's.


"Mac OS X is like living in a farmhouse in the country with no locks, and Windows is living in a house with bars on the windows in the bad part of town." -- Charlie Miller











botimage
Copyright 2013 DailyTech LLC. - RSS Feed | Advertise | About Us | Ethics | FAQ | Terms, Conditions & Privacy Information | Kristopher Kubicki